| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AP2 α modulates cystic fibrosis transmembrane conductance regulator function in the human intestine
|
Kumari, Vandana
|
|
2017
|
16 |
3 |
p. 327-334
8 p.
|
artikel
|
| 2 |
Applying recent advances in the science of CFTR-based therapeutics to improve outcomes in patients with cystic fibrosis
|
Clancy, JP
|
|
2017
|
16 |
3 |
p. e9-e10
nvt p.
|
artikel
|
| 3 |
Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia
|
Lehoux Dubois, C.
|
|
2017
|
16 |
3 |
p. 418-424
7 p.
|
artikel
|
| 4 |
Dietary intake and lipid profile in children and adolescents with cystic fibrosis
|
Woestenenk, Janna W.
|
|
2017
|
16 |
3 |
p. 410-417
8 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2017
|
16 |
3 |
p. ii-
1 p.
|
artikel
|
| 6 |
Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis
|
Blanchard, Ana C.
|
|
2017
|
16 |
3 |
p. 395-400
6 p.
|
artikel
|
| 7 |
Effect of freezing sputum on Pseudomonas aeruginosa population heterogeneity
|
Poonja, Ali
|
|
2017
|
16 |
3 |
p. 353-357
5 p.
|
artikel
|
| 8 |
Environmental scan of cystic fibrosis research worldwide
|
Kelly, Janice
|
|
2017
|
16 |
3 |
p. 367-370
4 p.
|
artikel
|
| 9 |
Immediate effects of lumacaftor/ivacaftor administration on lung function in patients with severe cystic fibrosis lung disease
|
Popowicz, Natalia
|
|
2017
|
16 |
3 |
p. 392-394
3 p.
|
artikel
|
| 10 |
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
|
Nichols, Dave P.
|
|
2017
|
16 |
3 |
p. 358-366
9 p.
|
artikel
|
| 11 |
Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione
|
Corti, Alessandro
|
|
2017
|
16 |
3 |
p. 342-345
4 p.
|
artikel
|
| 12 |
Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial
|
De Boeck, K
|
|
2017
|
16 |
3 |
p. 380-387
8 p.
|
artikel
|
| 13 |
Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L
|
MacKenzie, Isobel E.R.
|
|
2017
|
16 |
3 |
p. 335-341
7 p.
|
artikel
|
| 14 |
Multilocus amplicon sequencing of Pseudomonas aeruginosa cystic fibrosis airways isolates collected prior to and after early antipseudomonal chemotherapy
|
Fischer, Sebastian
|
|
2017
|
16 |
3 |
p. 346-352
7 p.
|
artikel
|
| 15 |
News
|
|
|
2017
|
16 |
3 |
p. 315-317
3 p.
|
artikel
|
| 16 |
Orkambi in patients with severe disease — Bumps in the road to CFTR modulation
|
Horsley, Alex
|
|
2017
|
16 |
3 |
p. 311-312
2 p.
|
artikel
|
| 17 |
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR
|
Donaldson, Scott H.
|
|
2017
|
16 |
3 |
p. 371-379
9 p.
|
artikel
|
| 18 |
Pseudomonas aeruginosa eradication: Finally moving the needle?
|
Cogen, Jonathan
|
|
2017
|
16 |
3 |
p. 309-310
2 p.
|
artikel
|
| 19 |
Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease
|
Hubert, Dominique
|
|
2017
|
16 |
3 |
p. 388-391
4 p.
|
artikel
|
| 20 |
The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis
|
Garinis, Angela C.
|
|
2017
|
16 |
3 |
p. 401-409
9 p.
|
artikel
|
| 21 |
The patient voice in research — Supporting actor or starring role?
|
Rowbotham, Nicola J
|
|
2017
|
16 |
3 |
p. 313-314
2 p.
|
artikel
|
| 22 |
The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis: A preliminary study
|
Ward, Nathan
|
|
2017
|
16 |
3 |
p. 425-432
8 p.
|
artikel
|
| 23 |
Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher
|
Szczesniak, Rhonda
|
|
2017
|
16 |
3 |
p. 318-326
9 p.
|
artikel
|
Tijdschrift beschrijving